Technical Analysis for BFRI - Biofrontera Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Calm After Storm | Range Contraction | -1.83% | |
| Lower Bollinger Band Walk | Weakness | -1.83% | |
| Earnings Movers | Other | -1.83% | |
| Wide Bands | Range Expansion | -1.83% |
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| Possible Inside Day | 1 day ago |
| Down 3% | 1 day ago |
| Down 2 % | 1 day ago |
| Down 1% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/15/2024
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Melanoma Antineoplastic Drugs Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis Non Melanoma Skin Cancer
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Melanoma Antineoplastic Drugs Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis Non Melanoma Skin Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.42 |
| 52 Week Low | 0.61 |
| Average Volume | 125,615 |
| 200-Day Moving Average | 3.98 |
| 50-Day Moving Average | 1.57 |
| 20-Day Moving Average | 1.52 |
| 10-Day Moving Average | 1.35 |
| Average True Range | 0.23 |
| RSI (14) | 35.90 |
| ADX | 17.92 |
| +DI | 17.79 |
| -DI | 27.52 |
| Chandelier Exit (Long, 3 ATRs) | 1.45 |
| Chandelier Exit (Short, 3 ATRs) | 1.70 |
| Upper Bollinger Bands | 2.03 |
| Lower Bollinger Band | 1.01 |
| Percent B (%b) | 0.05 |
| BandWidth | 66.71 |
| MACD Line | -0.13 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0729 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.18 | ||||
| Resistance 3 (R3) | 1.18 | 1.15 | 1.16 | ||
| Resistance 2 (R2) | 1.15 | 1.12 | 1.15 | 1.15 | |
| Resistance 1 (R1) | 1.11 | 1.11 | 1.10 | 1.11 | 1.15 |
| Pivot Point | 1.08 | 1.08 | 1.07 | 1.08 | 1.08 |
| Support 1 (S1) | 1.04 | 1.05 | 1.03 | 1.04 | 0.99 |
| Support 2 (S2) | 1.01 | 1.04 | 1.01 | 0.99 | |
| Support 3 (S3) | 0.97 | 1.01 | 0.98 | ||
| Support 4 (S4) | 0.97 |
